Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Buy
1,644
+204
+14% +$69.8K 0.09% 130
2026
Q1
$506K Sell
1,440
-213
-13% -$75.9K 0.09% 129
2025
Q4
$542K Buy
1,653
+109
+7% +$34.6K 0.09% 133
2025
Q3
$436K Buy
1,544
+265
+21% +$76.9K 0.08% 136
2025
Q2
$357K Sell
1,279
-493
-28% -$140K 0.08% 136
2025
Q1
$552K Buy
1,772
+102
+6% +$30.1K 0.14% 100
2024
Q4
$435K Buy
+1,670
New +$495K 0.11% 117

Other funds holding AMGN

Atlas Legacy Advisors's AMGN Position: Q2 2026 in Review

Atlas Legacy Advisors increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $69.8K and bringing the position to 1,644 shares worth $588K. The position accounts for 0.09% of the portfolio, ranked #130.

Atlas Legacy Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Atlas Legacy Advisors held 1,644 shares of Amgen worth $588K as of Q2 2026.
  • Atlas Legacy Advisors bought 204 Amgen shares in Q2 2026, an estimated $69.8K.
  • Amgen made up 0.09% of Atlas Legacy Advisors's portfolio in Q2 2026, its #130 holding.
  • Atlas Legacy Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Atlas Legacy Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.